Dana M Brantley-Sieders (Dana Brantley-Sieders)

Years Active: 2020-2021
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

David B Vaught, Alyssa R Merkel, Conor C Lynch, James R Edwards, Mohammed Noor Tantawy, Timothy Hilliard, Shan Wang, Todd Peterson, Rachelle W Johnson, Julie A Sterling, Dana M Brantley-Sieders
EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease. JBMR plus 5 (4) (2021)
Kalin Wilson, Eileen Shiuan, Dana M Brantley-Sieders
Oncogenic functions and therapeutic targeting of EphA2 in cancer. Oncogene 40 (14) (2021)
Eileen Shiuan, Ashwin Inala, Shan Wang, Wenqiang Song, Victoria Youngblood, Jin Chen, Dana M Brantley-Sieders
Host deficiency in ephrin-A1 inhibits breast cancer metastasis. F1000Research 9 (2020)
Eileen Shiuan, Ashwin Inala, Shan Wang, Wenqiang Song, Victoria Youngblood, Jin Chen, Dana M Brantley-Sieders
Host deficiency in ephrin-A1 inhibits breast cancer metastasis. F1000Research (2020)

Dana M Brantley-Sieders.css-eqlu8i{font-size:small;padding-left:4px;} (Dana Brantley-Sieders)